Stifel Financial Corp Purchases 23,055 Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Stifel Financial Corp lifted its position in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) by 53.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 66,470 shares of the company’s stock after buying an additional 23,055 shares during the quarter. Stifel Financial Corp’s holdings in Crescent Capital BDC were worth $1,230,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. Van ECK Associates Corp grew its stake in Crescent Capital BDC by 136.1% during the second quarter. Van ECK Associates Corp now owns 26,521 shares of the company’s stock worth $498,000 after purchasing an additional 15,288 shares during the period. Condor Capital Management boosted its holdings in shares of Crescent Capital BDC by 12.4% during the 2nd quarter. Condor Capital Management now owns 252,121 shares of the company’s stock worth $4,735,000 after buying an additional 27,801 shares in the last quarter. Sun Life Financial Inc. grew its position in shares of Crescent Capital BDC by 8.1% during the 2nd quarter. Sun Life Financial Inc. now owns 1,843,766 shares of the company’s stock worth $34,626,000 after buying an additional 137,684 shares during the period. XTX Topco Ltd acquired a new stake in shares of Crescent Capital BDC during the 2nd quarter worth approximately $195,000. Finally, Marshall Wace LLP bought a new stake in shares of Crescent Capital BDC in the 2nd quarter valued at $767,000. Institutional investors own 49.46% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Keefe, Bruyette & Woods increased their target price on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a research note on Monday, November 25th. LADENBURG THALM/SH SH started coverage on shares of Crescent Capital BDC in a report on Monday, September 30th. They set a “buy” rating and a $20.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, Crescent Capital BDC presently has an average rating of “Moderate Buy” and an average target price of $19.17.

Crescent Capital BDC Price Performance

Shares of CCAP opened at $19.52 on Monday. Crescent Capital BDC, Inc. has a 12-month low of $15.91 and a 12-month high of $20.03. The stock has a market cap of $723.45 million, a P/E ratio of 7.65 and a beta of 0.82. The business’s fifty day moving average is $18.92 and its 200 day moving average is $18.70. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 1.14.

Crescent Capital BDC Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Tuesday, December 31st will be issued a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a dividend yield of 8.61%. The ex-dividend date of this dividend is Tuesday, December 31st. This is a positive change from Crescent Capital BDC’s previous quarterly dividend of $0.07. Crescent Capital BDC’s dividend payout ratio is currently 65.88%.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.